Ratings by KeyBanc (Scott Schoenhaus)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/22/2024 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
3/20/2024 | Alight Solutions | ALIT | Maintain | Overweight (N/A) |
|
Details | ||
3/13/2024 | Teladoc | TDOC | Maintain | Sector Weight (N/A) |
|
Details | ||
3/5/2024 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
3/4/2024 | Absci Corp. | ABSI | Maintain | Overweight (N/A) |
|
Details | ||
2/29/2024 | Schrodinger | SDGR | Maintain | Overweight (N/A) |
|
Details | ||
2/28/2024 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
1/24/2024 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
1/5/2024 | R1 RCM Inc | RCM | Maintain | Overweight (N/A) |
|
Details | ||
1/5/2024 | Absci Corp. | ABSI | Maintain | Overweight (N/A) |
|
Details | ||
1/5/2024 | AbCellera Biologics | ABCL | Maintain | Overweight (N/A) |
|
Details | ||
12/5/2023 | Schrodinger | SDGR | New Coverage | Overweight (N/A) |
32.49 (27.00) |
-16.9% | Details | |
12/5/2023 | Certara Inc. | CERT | New Coverage | Sector Weight (N/A) |
14.64 (17.88) |
22.13% | Details | |
12/5/2023 | Absci Corp. | ABSI | New Coverage | Overweight (N/A) |
1.74 (5.68) |
226.44% | Details | |
12/5/2023 | AbCellera Biologics | ABCL | New Coverage | Overweight (N/A) |
4.83 (4.53) |
-6.21% | Details | |
11/8/2023 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
10/11/2023 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
10/11/2023 | Omnicell | OMCL | Downgrade | Sector Weight (Overweight) |
43.80 (29.23) |
-33.26% | Details | |
8/14/2023 | Oddity Tech Ltd | ODD | New Coverage | Overweight (N/A) |
46.35 (43.45) |
-6.26% | Details | |
8/4/2023 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
7/13/2023 | Recursion Pharmaceuticals | RXRX | Maintain | Overweight (N/A) |
|
Details | ||
7/13/2023 | Omnicell | OMCL | Maintain | Overweight (N/A) |
|
Details | ||
6/2/2023 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
5/25/2023 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
5/25/2023 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
5/3/2023 | Omnicell | OMCL | Maintain | Overweight (Overweight) |
|
Details | ||
4/20/2023 | Health Catalyst Inc. | HCAT | Upgrade | Overweight (Sector Weight) |
13.09 (7.53) |
-42.48% | Details | |
2/2/2023 | R1 RCM Inc | RCM | Maintain | Overweight (N/A) |
|
Details | ||
2/2/2023 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
2/2/2023 | Omnicell | OMCL | Maintain | Overweight (N/A) |
|
Details | ||
12/19/2022 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
12/5/2022 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
12/5/2022 | R1 RCM Inc | RCM | Maintain | Overweight (N/A) |
|
Details | ||
11/9/2022 | R1 RCM Inc | RCM | Maintain | Overweight (N/A) |
|
Details | ||
11/8/2022 | Benefitfocus | BNFT | Downgrade | Sector Weight (Overweight) |
10.39 (10.50) |
1.06% | Details | |
9/16/2022 | Veeva Systems | VEEV | New Coverage | Overweight (N/A) |
174.19 (231.69) |
33.01% | Details | |
9/16/2022 | Phreesia | PHR | New Coverage | Overweight (N/A) |
44.42 (23.93) |
-46.13% | Details | |
9/16/2022 | R1 RCM Inc | RCM | New Coverage | Overweight (N/A) |
21.20 (12.88) |
-39.25% | Details | |
9/16/2022 | Teladoc | TDOC | New Coverage | Sector Weight (N/A) |
31.67 (15.10) |
-52.32% | Details | |
9/16/2022 | Recursion Pharmaceuticals | RXRX | New Coverage | Overweight (N/A) |
13.47 (9.97) |
-25.98% | Details | |
9/16/2022 | Progyny | PGNY | New Coverage | Overweight (N/A) |
42.05 (38.15) |
-9.27% | Details | |
9/16/2022 | HealthEquity, Inc | HQY | New Coverage | Overweight (N/A) |
71.28 (81.63) |
14.52% | Details | |
9/16/2022 | GoodRx Holdings Inc. | GDRX | New Coverage | Sector Weight (N/A) |
6.42 (7.10) |
10.59% | Details | |
9/16/2022 | Health Catalyst Inc. | HCAT | New Coverage | Sector Weight (N/A) |
11.17 (7.53) |
-32.59% | Details | |
9/16/2022 | Omnicell | OMCL | New Coverage | Overweight (N/A) |
97.37 (29.23) |
-69.98% | Details | |
9/16/2022 | Allscripts | MDRX | New Coverage | Sector Weight (N/A) |
16.51 (6.81) |
-58.75% | Details | |
9/16/2022 | HealthEquity, Inc | HQY | New Coverage | Overweight (N/A) |
71.28 (81.63) |
14.52% | Details | |
9/16/2022 | Doximity Inc | DOCS | New Coverage | Sector Weight (N/A) |
33.14 (26.91) |
-18.8% | Details | |
9/16/2022 | Benefitfocus | BNFT | New Coverage | Overweight (N/A) |
6.71 (10.50) |
56.48% | Details | |
9/16/2022 | Alight Solutions | ALIT | New Coverage | Overweight (N/A) |
7.89 (9.85) |
24.84% | Details |